{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:56:31Z","timestamp":1787237791152,"version":"build-2736575974"},"reference-count":376,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.semcancer.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T16:45:08Z","timestamp":1678207508000},"page":"70-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges"],"prefix":"10.1016","volume":"91","author":[{"given":"Georgios","family":"Papavasileiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tsilingiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia G.","family":"Vallianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Karampela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faidon","family":"Magkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dalamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2023.03.002_bib1","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13679-019-00364-y","article-title":"The role of adipokines in breast cancer: current evidence and perspectives","volume":"8","author":"Christodoulatos","year":"2019","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2023.03.002_bib4","first-page":"126","article-title":"Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes","volume":"40","author":"Mitchell","year":"2022","journal-title":"Urol. Oncol. Semin Orig. Invest."},{"key":"10.1016\/j.semcancer.2023.03.002_bib5","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2023.03.002_bib6","first-page":"8","article-title":"Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990\u20132019","author":"Zi","year":"2021","journal-title":"Mil. Med Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib8","volume":"vol. 37","author":"Al-Bayati","year":"2019"},{"key":"10.1016\/j.semcancer.2023.03.002_bib9","first-page":"228","article-title":"The risk factors of prostate cancer and its prevention: a literature review","volume":"48","author":"Perdana","year":"2016","journal-title":"Acta Med Indones."},{"key":"10.1016\/j.semcancer.2023.03.002_bib10","unstructured":"Obesity and overweight n.d. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib11","first-page":"69","article-title":"Global patterns in excess body weight and the associated cancer burden","author":"Sung","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2023.03.002_bib12","unstructured":"Obesity n.d. \u3008https:\/\/www.who.int\/health-topics\/obesity#tab=tab_1\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","article-title":"The obesity transition: stages of the global epidemic","volume":"7","author":"Jaacks","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib14","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Body fatness and weight gain and the risk of cancer. Available at dietandcancerreport.org."},{"key":"10.1016\/j.semcancer.2023.03.002_bib15","doi-asserted-by":"crossref","unstructured":"De Pergola G., Silvestris F. Obesity as a major risk factor for cancer. vol. 2013. 2013. https:\/\/doi.org\/10.1155\/2013\/291546.","DOI":"10.1155\/2013\/291546"},{"key":"10.1016\/j.semcancer.2023.03.002_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7754\/Clin.Lab.2012.121112","article-title":"Correlates of serum resistin in elderly, non-diabetic patients with chronic kidney disease","volume":"59","author":"Marouga","year":"2013","journal-title":"Clin. Lab"},{"key":"10.1016\/j.semcancer.2023.03.002_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.maturitas.2008.03.012","article-title":"Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight\/obese postmenopausal women","volume":"59","author":"Hroussalas","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.semcancer.2023.03.002_bib18","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3748\/wjg.v17.i12.1614","article-title":"Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR","volume":"17","author":"Pavlidou","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","article-title":"Deciphering the association between psoriasis and obesity: current evidence and treatment considerations","volume":"9","author":"Paroutoglou","year":"2020","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jdv.13700","article-title":"Prevalence of psoriatic arthritis and its correlates among patients with psoriasis in Greece: results from a large retrospective study","volume":"30","author":"Papadavid","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib21","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaad.2013.09.014","article-title":"Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study","volume":"69","author":"Dalamaga","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11325-012-0749-4","article-title":"Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea","volume":"17","author":"Dalamaga","year":"2013","journal-title":"Sleep. Breath."},{"key":"10.1016\/j.semcancer.2023.03.002_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13679-020-00397-8","article-title":"Autoantibody production in obesity: is there evidence for a link between obesity and autoimmunity","volume":"9","author":"Tsigalou","year":"2020","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3315\/jdcr.2012.1104","article-title":"Lobomycosis: a case from Southeastern Europe and review of the literature","volume":"6","author":"Papadavid","year":"2012","journal-title":"J. Dermatol. Case Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib25","article-title":"Understanding the Co-epidemic of obesity and COVID-19: current evidence, comparison with previous epidemics","volume":"vol. 10","author":"Dalamaga","year":"2021","journal-title":"Mech., Prev. Ther. Perspect."},{"key":"10.1016\/j.semcancer.2023.03.002_bib26","first-page":"14","article-title":"Management of hematologic malignancies in the Era of COVID-19 pandemic: pathogenetic mechanisms, impact of obesity, perspectives, and challenges","author":"Tsilingiris","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2023.03.002_bib27","first-page":"9","article-title":"The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis","author":"Guh","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.semcancer.2023.03.002_bib28","doi-asserted-by":"crossref","unstructured":"Obesity and carcinogenesis: Historical perspective Obesity and carcinogenesis: historical perspective1\u20192 1987. \u3008https:\/\/doi.org\/10.1093\/ajcn\/45.1.271\u3009.","DOI":"10.1093\/ajcn\/45.1.271"},{"key":"10.1016\/j.semcancer.2023.03.002_bib29","unstructured":"How many cancers are linked to obesity & inactivity? | WCRF International n.d. \u3008https:\/\/www.wcrf.org\/researchwefund\/how-many-cancers-are-actually-linked-to-obesity-and-physical-activity\/\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ijc.31553","article-title":"Quantitative association between body mass index and the risk of cancer: A global Meta-analysis of prospective cohort studies","volume":"143","author":"Fang","year":"2018","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib31","first-page":"1451","article-title":"B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece","volume":"21","author":"Dalamaga","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib32","first-page":"11","article-title":"Circulating omentin-1 as a biomarker at the intersection of postmenopausal breast cancer occurrence and cardiometabolic risk: an observational cross-sectional study","author":"Christodoulatos","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.semcancer.2023.03.002_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.lungcan.2018.10.010","article-title":"Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer","volume":"125","author":"Sotiropoulos","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib34","doi-asserted-by":"crossref","unstructured":"Dalamaga M., Christodoulatos G.S. Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies. vol. 23. 2015.","DOI":"10.1515\/hmbci-2015-0016"},{"key":"10.1016\/j.semcancer.2023.03.002_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1468-3083.2007.02520.x","article-title":"Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients","volume":"22","author":"Dalamaga","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib36","unstructured":"Prostate cancer statistics | World Cancer Research Fund International n.d. \u3008https:\/\/www.wcrf.org\/cancer-trends\/prostate-cancer-statistics\/\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib37","unstructured":"Kidney cancer statistics | World Cancer Research Fund International n.d. \u3008https:\/\/www.wcrf.org\/cancer-trends\/kidney-cancer-statistics\/\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib38","first-page":"22","article-title":"The sirenic links between diabetes, obesity, and bladder cancer","author":"Gill","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib39","first-page":"10","article-title":"Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews","author":"Shi","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.euf.2016.11.009","article-title":"Body composition in relation to clinical outcomes in renal cell cancer: a systematic review and meta-analysis","volume":"4","author":"Vrieling","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.semcancer.2023.03.002_bib41","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/ijo.2015.111","article-title":"Visceral adipose tissue measured by computed tomography and high-grade prostate cancer after radical prostatectomy","volume":"39","author":"Ohwaki","year":"2015","journal-title":"Int J. Obes."},{"key":"10.1016\/j.semcancer.2023.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13088","article-title":"Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence","volume":"22","author":"Silveira","year":"2021","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib43","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2023.03.002_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-019-00552-z","article-title":"The value of four imaging modalities in diagnosing lymph node involvement in rectal cancer: an overview and adjusted indirect comparison","author":"Gao","year":"2019","journal-title":"Clin. Exp. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib45","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2023.03.002_bib46","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/bjc.2017.106","article-title":"Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: Meta-analysis of individual participant data of seven prospective cohorts in Europe","volume":"116","author":"Freisling","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib47","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/ijc.27934","article-title":"An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies","volume":"132","author":"Purdue","year":"2013","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib50","first-page":"107","article-title":"Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies","author":"Keum","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2023.03.002_bib51","first-page":"471","article-title":"Obesity and kidney cancer risk in women - a meta-analysis (1992-2008)","volume":"10","author":"Mathew","year":"2009","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canep.2018.07.002","article-title":"Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis","volume":"56","author":"Callahan","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib53","first-page":"97","article-title":"The association between BMI and kidney cancer risk an updated dose-response meta-analysis in accordance with PRISMA guideline","author":"Liu","year":"2018","journal-title":"Med (U. S. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/CEJ.0000000000000231","article-title":"Body mass index and the risk of cancer in women compared with men: a meta-analysis of prospective cohort studies","volume":"26","author":"Xue","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib55","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/obr.12705","article-title":"Body fatness at a young age and risks of eight types of cancer: systematic review and meta-analysis of observational studies","volume":"19","author":"Hidayat","year":"2018","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib56","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/ijc.28813","article-title":"Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies","volume":"135","author":"Wang","year":"2014","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib57","first-page":"279","article-title":"Obesity and kidney cancer risk in men - a meta-analysis (1992-2008)","volume":"10","author":"Ildaphonse","year":"2009","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib58","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1054\/bjoc.2001.2040","article-title":"Obesity and renal cell cancer \u2013 a quantitative review","volume":"85","author":"Bergstr\u00f6m","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2023.03.002_bib60","volume":"vol. 10","author":"Argyrakopoulou","year":"2021","journal-title":"Gend. Differ. Obes. -Relat. Cancers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib61","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","article-title":"Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of disease study 2015","volume":"389","author":"Reitsma","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2023.03.002_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.nutr.21.1.323","article-title":"Successful weight loss maintenance","volume":"21","author":"Wing","year":"2001","journal-title":"Annu Rev. Nutr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib63","first-page":"16","article-title":"The influence of obesity-related factors in the etiology of renal cell carcinoma-a mendelian randomization study","author":"Johansson","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib64","first-page":"19","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","author":"Larsson","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib65","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/ijc.33338","article-title":"Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study","volume":"148","author":"Dimou","year":"2021","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2023.03.002_bib67","first-page":"1040","article-title":"Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies","volume":"26","author":"Lazaros","year":"2021","journal-title":"JBUON"},{"key":"10.1016\/j.semcancer.2023.03.002_bib68","first-page":"10","article-title":"Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib69","doi-asserted-by":"crossref","first-page":"33990","DOI":"10.18632\/oncotarget.16722","article-title":"Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib70","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.7314\/APJCP.2013.14.5.3117","article-title":"Obesity and risk of bladder cancer: a meta-analysis of cohort studies","volume":"14","author":"Qin","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.semcancer.2023.03.002_bib71","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00345-019-02690-1","article-title":"Association of body mass index with bladder cancer risk in men depends on abdominal obesity","volume":"37","author":"Choi","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib73","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib74","article-title":"Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis","volume":"vol. 17","author":"MacInnis","year":"2006"},{"key":"10.1016\/j.semcancer.2023.03.002_bib75","first-page":"431","article-title":"Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen","volume":"31","author":"Harrison","year":"2020","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib76","volume":"vol. 12","author":"Berger","year":"2019"},{"key":"10.1016\/j.semcancer.2023.03.002_bib77","doi-asserted-by":"crossref","first-page":"97584","DOI":"10.18632\/oncotarget.20930","article-title":"Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib78","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3892\/ol.2014.2841","article-title":"Impact of obesity upon prostate cancer-associated mortality: a meta-analysis of 17 cohort studies","volume":"9","author":"Zhang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2023.03.002_bib79","first-page":"9","article-title":"Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: A dose-response meta-analysis of 29, 464 patients","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib80","volume":"vol. 36","author":"Esposito","year":"2013"},{"key":"10.1016\/j.semcancer.2023.03.002_bib81","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/annonc\/mdr603","article-title":"Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studies","volume":"23","author":"Discacciati","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxm006","article-title":"Obesity and prostate cancer: making sense out of apparently conflicting data","volume":"29","author":"Freedland","year":"2007","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib83","first-page":"1603","article-title":"The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium","volume":"26","author":"Davies","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib84","first-page":"12","article-title":"The causal relationships between extrinsic exposures and risk of prostate cancer: a phenome-wide mendelian randomization study","author":"Gu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib85","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eururo.2011.05.038","article-title":"EAU guidelines on testicular cancer: 2011 update","volume":"60","author":"Albers","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib86","unstructured":"Obesity, weight and cancer risk - Preventing cancer | World Cancer Research Fund n.d. \u3008https:\/\/www.wcrf-uk.org\/preventing-cancer\/what-can-increase-your-risk-of-cancer\/obesity-weight-and-cancer-risk\/\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib87","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.bjc.6605934","article-title":"A systematic review and meta-analysis of the relationship between body size and testicular cancer","volume":"103","author":"Lerro","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib88","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.canep.2010.07.006","article-title":"Maternal body mass index and risk of testicular cancer in male offspring: a systematic review and meta-analysis","volume":"34","author":"Alam","year":"2010","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib89","first-page":"11","article-title":"Genetically predicted education attainment in relation to somatic and mental health","author":"Yuan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib90","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/andr.12388","article-title":"Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk","volume":"5","author":"Levy","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.semcancer.2023.03.002_bib91","doi-asserted-by":"crossref","unstructured":"Pieper D., Koensgen N., Breuing J., Ge L., Wegewitz U. How is AMSTAR applied by authors-a call for better reporting n.d. https:\/\/doi.org\/10.1186\/s12874\u2013018-0520-z.","DOI":"10.1186\/s12874-018-0520-z"},{"key":"10.1016\/j.semcancer.2023.03.002_bib92","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semcancer.2023.03.002_bib93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13643-022-02029-9","article-title":"AMSTAR 2 appraisal of systematic reviews and meta-analyses in the field of heart failure from high-impact journals","volume":"11","author":"Li","year":"2022","journal-title":"Syst. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.semcancer.2023.03.002_bib95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2016.07.042","article-title":"Periprostatic fat: a risk factor for prostate cancer","volume":"98","author":"Tan","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.semcancer.2023.03.002_bib96","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1258\/ebm.2012.012131","article-title":"Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma","volume":"237","author":"Ribeiro","year":"2012","journal-title":"Exp. Biol. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10061291","article-title":"Perirenal adipose tissue\u2014current knowledge and future opportunities","volume":"10","author":"Grigora\u0219","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib98","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.semcancer.2021.05.008","article-title":"The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era","volume":"73","author":"Spyrou","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib99","first-page":"13","article-title":"Mycobiome and cancer: what is the evidence","author":"Vallianou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib100","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-15-1551","article-title":"A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk","volume":"76","author":"Travis","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib101","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","article-title":"The role of the IGF system in cancer: from basic to clinical studies and clinical applications","volume":"63","author":"Moschos","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.semcancer.2023.03.002_bib102","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1590\/S0004-27302009000800010","article-title":"IGF-I, insulin and prostate cancer","volume":"53","author":"Lima","year":"2009","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2023.03.002_bib103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/andr.12658","article-title":"IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches","volume":"7","author":"Selfe","year":"2019","journal-title":"Andrology"},{"key":"10.1016\/j.semcancer.2023.03.002_bib104","first-page":"6","article-title":"Circulating Insulin-Like Growth Factor 1\u2013Related Biomarkers and Risk of Lethal Prostate Cancer","author":"Ma","year":"2022","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2023.03.002_bib106","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.critrevonc.2005.10.003","article-title":"Insulin-Like Growth Factor (IGF) family and prostate cancer","volume":"58","author":"Gennigens","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: the increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib108","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","article-title":"Type 2 diabetes and cancer: An umbrella review of observational and mendelian randomization studies","volume":"30","author":"Pearson-Stuttard","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib109","first-page":"16","article-title":"Insulin-like growth factor-1 signaling in renal cell carcinoma","author":"Tracz","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib111","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djs399","article-title":"Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803","volume":"104","author":"Meyerhardt","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2023.03.002_bib112","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1054\/bjoc.2001.1961","article-title":"Insulin-like growth factor-I and prostate cancer: a meta-analysis","volume":"85","author":"Shi","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-149-7-200810070-00006","article-title":"Insulin-like growth factors, their binding proteins, and prostate cancer risk: Analysis of individual patient data from 12 prospective studies","volume":"149","author":"Roddam","year":"2008","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib114","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2023.03.002_bib115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/carcin\/bgab031","article-title":"High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: A Mendelian randomization study","volume":"42","author":"Chen","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2023.03.002_bib116","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mc.23334","article-title":"Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk","volume":"60","author":"Tsai","year":"2021","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcancer.2023.03.002_bib117","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/ijc.33416","article-title":"Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank","volume":"148","author":"Watts","year":"2021","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib118","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1002\/cam4.3345","article-title":"Insulin-like growth factor-1 and site-specific cancers: A Mendelian randomization study","volume":"9","author":"Larsson","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib119","article-title":"Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis","author":"Watts","year":"2022","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib120","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ijc.30206","article-title":"Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels","volume":"139","author":"Bonilla","year":"2016","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib121","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41419-020-03348-2","article-title":"Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p\/IGF2R regulation","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2023.03.002_bib122","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1038\/s41388-019-0880-9","article-title":"Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A\/BIM signaling in a double-transgenic mouse model","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2023.03.002_bib123","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib124","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib125","first-page":"199","article-title":"Obesity I: Overview and molecular and biochemical mechanisms","author":"Lustig","year":"2022","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.semcancer.2023.03.002_bib126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41391-018-0081-6","article-title":"Estrogens and prostate cancer","volume":"22","author":"Dobbs","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.semcancer.2023.03.002_bib127","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.tem.2020.07.002","article-title":"The sex bias of cancer","volume":"31","author":"Costa","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2023.03.002_bib128","first-page":"19","article-title":"Androgens, diabetes and prostate cancer","author":"Grossmann","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4239\/wjd.v11.i6.227","article-title":"Diabetes and cancer: epidemiological and biological links","volume":"11","author":"Wang","year":"2020","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.semcancer.2023.03.002_bib130","first-page":"137","article-title":"Obesity and prostate cancer","volume":"vol. 208","author":"Cao","year":"2016"},{"key":"10.1016\/j.semcancer.2023.03.002_bib131","first-page":"18","article-title":"Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study","author":"Hayes","year":"2022","journal-title":"PLoS Genet"},{"key":"10.1016\/j.semcancer.2023.03.002_bib132","volume":"vol. 208","author":"Wilson","year":"2016"},{"key":"10.1016\/j.semcancer.2023.03.002_bib133","first-page":"13","article-title":"Sex and gender differences in kidney cancer: clinical and experimental evidence","author":"Peired","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib134","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1158\/1055-9965.EPI-20-0246","article-title":"Association of sex hormones with risk of cancers of the pancreas, kidney, and brain in the UK Biobank Cohort Study","volume":"29","author":"Peila","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib135","first-page":"20","article-title":"Systematic review of Mendelian randomization studies on risk of cancer","author":"Markozannes","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib136","first-page":"103","article-title":"Spotlight on gender-specific disparities in bladder cancer","volume":"87","author":"Mancini","year":"2020","journal-title":"Urol. J."},{"key":"10.1016\/j.semcancer.2023.03.002_bib137","first-page":"287","article-title":"Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens","volume":"31","author":"Zhang","year":"2013","journal-title":"J. Environ. Sci. Heal - Part C. Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib138","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/apm.13183","article-title":"The inequality of females in bladder cancer","volume":"129","author":"Hyldgaard","year":"2021","journal-title":"APMIS"},{"key":"10.1016\/j.semcancer.2023.03.002_bib139","first-page":"10","article-title":"Testicular cancer: genes, environment, hormones","author":"De Toni","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2023.03.002_bib140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1387\/ijdb.130015fg","article-title":"Effect of endogenous and exogenous hormones on testicular cancer: The epidemiological evidence","volume":"57","author":"Giannandrea","year":"2013","journal-title":"Int J. Dev. Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib141","unstructured":"Rajpert-De Meyts E., Skakkebaek N.E., Toppari J. Testicular Cancer Pathogenesis, Diagnosis and Endocrine Aspects. 2000."},{"key":"10.1016\/j.semcancer.2023.03.002_bib142","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.metabol.2018.11.007","article-title":"Could the endocrine disruptor bisphenol-A be implicated in the pathogenesis of oral and oropharyngeal cancer? Metabolic considerations and future directions","volume":"91","author":"Emfietzoglou","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.semcancer.2023.03.002_bib143","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib144","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2174\/1381612827666210303143442","article-title":"Chronic inflammation and cancer: the role of endothelial dysfunction and vascular inflammation","volume":"27","author":"Malhab","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.semcancer.2023.03.002_bib145","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib146","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib147","first-page":"10","article-title":"Role of complement in regulating inflammation processes in renal and prostate cancers","author":"Netti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.semcancer.2023.03.002_bib148","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib149","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bju.12452","article-title":"Inflammation and prostate cancer: the role of interleukin 6 (IL-6)","volume":"113","author":"Nguyen","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.semcancer.2023.03.002_bib150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.02.025","article-title":"Interleukin 32, inflammation and cancer","volume":"174","author":"Hong","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.semcancer.2023.03.002_bib151","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3810\/pgm.2013.07.2679","article-title":"The impact of obesity on benign and malignant urologic conditions","volume":"125","author":"Chu","year":"2013","journal-title":"Post. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib152","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: inflammatory storms","volume":"20","author":"de Bono","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib153","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-015-0812-2","article-title":"Inflammation and prostate cancer: friends or foe","volume":"64","author":"Taverna","year":"2015","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib154","first-page":"8","article-title":"Obesity, inflammation, and prostate cancer","author":"Fujita","year":"2019","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/pcan.2017.31","article-title":"Periprostatic adipose inflammation is associated with high-grade prostate cancer","volume":"20","author":"Gucalp","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.semcancer.2023.03.002_bib156","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13679-020-00396-9","article-title":"The implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity","volume":"9","author":"Koliaki","year":"2020","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib157","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s13679-019-00360-2","article-title":"The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox","volume":"8","author":"Karampela","year":"2019","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib158","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2010.05.004","article-title":"Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT","volume":"67","author":"Kassi","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.semcancer.2023.03.002_bib159","first-page":"20","article-title":"Adipose tissue, obesity and adiponectin: Role in endocrine cancer risk","author":"Tumminia","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib160","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1016\/j.clnu.2021.10.019","article-title":"Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer","volume":"40","author":"Ke","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249393","article-title":"The role of nitric oxide in cancer: master regulator or NOt","volume":"21","author":"Khan","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib162","first-page":"260","article-title":"Chronic inflammation and bladder cancer","volume":"25","author":"Michaud","year":"2007","journal-title":"Urol. Oncol. Semin Orig. Invest."},{"key":"10.1016\/j.semcancer.2023.03.002_bib163","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/carcin\/10.3.547","article-title":"Urinary excretion of nitrate, nitrite and N-nitroso compounds in Schistosomiasis and bilharzia bladder cancer patients","volume":"10","author":"Tricker","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2023.03.002_bib164","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/carcin\/15.4.619","article-title":"Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients","volume":"15","author":"Mostafa","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2023.03.002_bib165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00240-003-0302-9","article-title":"Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis","volume":"31","author":"Lin","year":"2003","journal-title":"Urol. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib166","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.juro.2012.09.030","article-title":"Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma","volume":"189","author":"Zhu","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib167","first-page":"23","article-title":"Renal cell cancer and obesity","author":"Gluba-Brz\u00f3zka","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib168","first-page":"3","article-title":"What is oxidative stress","volume":"vol. 49","author":"Betteridge","year":"2000"},{"key":"10.1016\/j.semcancer.2023.03.002_bib169","doi-asserted-by":"crossref","first-page":"220","DOI":"10.14694\/EdBook_AM.2015.35.220","article-title":"Metabolism and oxidative stress response pathways in kidney cancer: a tale of chance and necessity","author":"Sourbier","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. B"},{"key":"10.1016\/j.semcancer.2023.03.002_bib170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/1744666X.2015.983082","article-title":"Immunological basis in the pathogenesis and treatment of bladder cancer","volume":"11","author":"Thompson","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib171","first-page":"41","article-title":"Inflammation and prostate cancer","volume":"vol. 1095","author":"Tewari","year":"2018"},{"key":"10.1016\/j.semcancer.2023.03.002_bib172","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2008.79","article-title":"The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis","volume":"27","author":"Frohlich","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2023.03.002_bib173","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib174","first-page":"124","article-title":"Ectopic fat depots and cardiovascular disease","author":"Britton","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2023.03.002_bib175","first-page":"49","article-title":"Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity","volume":"vol. 73","author":"Goran","year":"2012"},{"key":"10.1016\/j.semcancer.2023.03.002_bib176","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/ijbs.29599","article-title":"Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer","volume":"15","author":"Divella","year":"2019","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib177","first-page":"5","article-title":"Crosstalk between adiponectin and IGF-IR in breast cancer","author":"Mauro","year":"2015","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib178","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.17320","article-title":"The troubling link between non-alcoholic fatty liver disease (NAFLD) and Extrahepatic cancers (EHC)","author":"Venniyoor","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.semcancer.2023.03.002_bib179","volume":"vol. 121","author":"Nassar","year":"2018"},{"key":"10.1016\/j.semcancer.2023.03.002_bib180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coemr.2020.02.007","article-title":"Periprostatic adipose tissue: a heavy player in prostate cancer progression","volume":"10","author":"Est\u00e8ve","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib181","first-page":"11","article-title":"Prostate cancer progression: as a matter of fats","author":"Scaglia","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib182","first-page":"13","article-title":"Periprostatic adipose tissue microenvironment: metabolic and hormonal pathways during prostate cancer progression","author":"Sacca","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2023.03.002_bib183","first-page":"10","article-title":"Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue","author":"Ribeiro","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib184","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2152\/jmi.65.9","article-title":"Adipose tissue: critical contributor to the development of prostate cancer","volume":"65","author":"Uehara","year":"2018","journal-title":"J. Med Invest."},{"issue":"2021\u20132039","key":"10.1016\/j.semcancer.2023.03.002_bib185","article-title":"The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy","volume":"33","author":"Wei","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2023.03.002_bib186","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/1354750X.2015.1118536","article-title":"Circulating resistin is a significant predictor of mortality independently from cardiovascular comorbidities in elderly, non-diabetic subjects with chronic kidney disease","volume":"21","author":"Marouga","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib187","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12020-018-1550-3","article-title":"Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors","volume":"61","author":"Stratigou","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.semcancer.2023.03.002_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100208","article-title":"Of mice and men: considerations on adipose tissue physiology in animal models of obesity and human studies","volume":"15","author":"Lempesis","year":"2022","journal-title":"Metab. Open"},{"key":"10.1016\/j.semcancer.2023.03.002_bib189","first-page":"155","article-title":"Casual roles of circulating adiponectin in osteoporosis and cancers","author":"He","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.semcancer.2023.03.002_bib190","first-page":"11","article-title":"Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis","author":"Burton","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib191","doi-asserted-by":"crossref","first-page":"48671","DOI":"10.18632\/oncotarget.8932","article-title":"Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib192","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13277-014-2654-x","article-title":"Causal relevance of circulating adiponectin with cancer: a meta-analysis implementing Mendelian randomization","volume":"36","author":"Pei","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib193","first-page":"8","article-title":"Association of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: evidence from a meta-analysis","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib194","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1724600819898696","article-title":"Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: a meta-analysis","volume":"35","author":"Fang","year":"2020","journal-title":"Int J. Biol. Markers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib195","first-page":"125","article-title":"Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis","author":"Arjmand","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.semcancer.2023.03.002_bib196","volume":"vol. 23","author":"Angel","year":"2020"},{"key":"10.1016\/j.semcancer.2023.03.002_bib197","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1354750X.2019.1634763","article-title":"Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis","volume":"24","author":"Yap","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib198","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.orcp.2019.03.006","article-title":"Circulating adipokines and risk of obesity related cancers: a systematic review and meta-analysis","volume":"13","author":"Yoon","year":"2019","journal-title":"Obes. Res Clin. Pr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109239","article-title":"Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis","volume":"129","author":"Perumal","year":"2019","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.semcancer.2023.03.002_bib200","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4103\/jcrt.JCRT_848_17","article-title":"Association between leptin level and renal cell carcinoma susceptibility and progression: a meta-analysis","volume":"14","author":"Zhu","year":"2018","journal-title":"J. Cancer Res Ther."},{"key":"10.1016\/j.semcancer.2023.03.002_bib201","doi-asserted-by":"crossref","first-page":"81049","DOI":"10.18632\/oncotarget.12747","article-title":"Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: Evidence from a meta-analysis and pooled-review","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib202","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm1010-1097","article-title":"A historical perspective on leptin","volume":"16","author":"Coleman","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib203","doi-asserted-by":"crossref","first-page":"35556","DOI":"10.18632\/oncotarget.5574","article-title":"Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma","volume":"6","author":"Alshaker","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnaa027","article-title":"Tissue-specific effects of leptin on glucose and lipid metabolism","volume":"42","author":"Pereira","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib205","volume":"vol. 182","author":"Stolzenberg-Solomon","year":"2015"},{"key":"10.1016\/j.semcancer.2023.03.002_bib206","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbadis.2008.07.005","article-title":"c-Jun NH2-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt","volume":"1782","author":"Miyazaki","year":"2008","journal-title":"Biochim Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.semcancer.2023.03.002_bib207","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2613.2010.00726.x","article-title":"Prostate cancer cell proliferation and angiogenesis in different obese mice models","volume":"91","author":"Ribeiro","year":"2010","journal-title":"Int J. Exp. Pathol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib208","first-page":"8341","article-title":"Leptin promotes proliferation and inhibits apoptosis of prostate cancer cells by regulating ERK1\/2 signaling pathway","volume":"24","author":"Xu","year":"2020","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib209","first-page":"10","article-title":"Adipocyte secreted factors enhance aggressiveness of prostate carcinoma cells","author":"Moreira","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib211","first-page":"1874","article-title":"Resistin: an inflammatory cytokine with multi-faceted roles in cancer","author":"Sudan","year":"2020","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib212","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2023.03.002_bib213","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/bmm.13.99","article-title":"Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives","volume":"8","author":"Dalamaga","year":"2014","journal-title":"Biomark. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib214","doi-asserted-by":"crossref","unstructured":"Spyrou N., Avgerinos K.I., Mantzoros C.S., Dalamaga M. Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies. vol. 7. 2018.","DOI":"10.1007\/s13679-018-0318-7"},{"key":"10.1016\/j.semcancer.2023.03.002_bib215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/bmm.13.99","article-title":"Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives","volume":"8","author":"Dalamaga","year":"2014","journal-title":"Biomark. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib216","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2019.03.002","article-title":"Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis: a prospective observational study","volume":"119","author":"Karampela","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.semcancer.2023.03.002_bib217","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.21037\/tau.2018.11.10","article-title":"Prognostic biomarkers in renal cell carcinoma: is there a relationship with obesity","volume":"8","author":"Rajandram","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib218","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cyto.2015.09.004","article-title":"Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer","volume":"77","author":"Shen","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.semcancer.2023.03.002_bib219","first-page":"57","article-title":"Adipose tissue, obesity and adipokines: role in cancer promotion","volume":"21","author":"Booth","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.semcancer.2023.03.002_bib220","first-page":"14","article-title":"Revised estimates for the number of human and bacteria cells in the body","author":"Sender","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib221","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib222","first-page":"15","article-title":"The human microbiome and its link in prostate cancer risk and pathogenesis","author":"Katongole","year":"2020","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib223","first-page":"308","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"10.1016\/j.semcancer.2023.03.002_bib224","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2018.12.043","article-title":"The microbiome and genitourinary cancer: a collaborative review","volume":"75","author":"Markowski","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib225","first-page":"20","article-title":"The microbiome and prostate cancer risk","author":"Wheeler","year":"2019","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib226","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcancer.2020.06.011","article-title":"The influence of dysbiosis on kidney stones that risk up renal cell carcinoma (RCC","volume":"70","author":"Gupta","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib227","first-page":"225","article-title":"The urinary microbiome and bladder cancer: susceptibility and immune responsiveness","volume":"6","author":"Andolfi","year":"2020","journal-title":"Bl. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib228","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrurol.2015.292","article-title":"The interplay of extracellular matrix and microbiome in urothelial bladder cancer","volume":"13","author":"Alfano","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib229","first-page":"11","article-title":"Prostate microbiota and prostate cancer: a new trend in treatment","author":"Che","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12092648","article-title":"The crosstalk between prostate cancer and microbiota inflammation: Nutraceutical products are useful to balance this interplay","volume":"12","author":"Crocetto","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib231","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib232","first-page":"41","article-title":"Dysbiotic microbes and how to find them: a review of microbiome profiling in prostate cancer","author":"Salachan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib233","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","article-title":"Microbiome and malignancy","volume":"10","author":"Plottel","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semcancer.2023.03.002_bib234","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1158\/0008-5472.CAN-19-0566","article-title":"Cancer and the circadian clock","volume":"79","author":"Shafi","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib235","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1055-9965.EPI-16-1030","article-title":"Circadian disruption and prostate cancer risk: an updated review of epidemiological evidences","volume":"26","author":"Wendeu-Foyet","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib236","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41574-019-0237-z","article-title":"Interconnection between circadian clocks and thyroid function","volume":"15","author":"Ikegami","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib237","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00114-007-0335-y","article-title":"Chronodisruption and cancer","volume":"95","author":"Erren","year":"2008","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.semcancer.2023.03.002_bib238","first-page":"52","article-title":"Interactions between endocrine and circadian systems","author":"Tsang","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib239","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0306-9877(02)00173-1","article-title":"Does the pineal gland have a role in the psychological mechanisms involved in the progression of cancer","volume":"59","author":"Callaghan","year":"2002","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.semcancer.2023.03.002_bib240","first-page":"1","article-title":"Association between night-shift work and cancer risk: Updated systematic review and meta-analysis","volume":"10","author":"Dun","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib241","unstructured":"Role of circadian rhythm disorders on EMT and tumour-immune interactions in endocrine-related cancers - PubMed n.d. \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/33446614\/\u3009 (accessed October 31, 2022)."},{"key":"10.1016\/j.semcancer.2023.03.002_bib242","doi-asserted-by":"crossref","first-page":"R305","DOI":"10.1530\/ERC-19-0094","article-title":"Clock genes and cancer development in particular in endocrine tissues","volume":"26","author":"Angelousi","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib243","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1055-9965.EPI-12-0116","article-title":"Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies","volume":"21","author":"Sigurdardottir","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib244","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1467-789X.2012.01010.x","article-title":"A systematic review of the impact of weight loss on cancer incidence and mortality","volume":"13","author":"Birks","year":"2012","journal-title":"Obes. Rev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib245","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/oby.22936","article-title":"Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the look AHEAD randomized clinical trial","volume":"28","author":"Yeh","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.semcancer.2023.03.002_bib246","first-page":"3","article-title":"Intentional weight loss and obesity-related cancer risk","author":"Luo","year":"2019","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib247","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11695-018-3501-8","article-title":"Cancer risk following bariatric surgery\u2014systematic review and meta-analysis of national population-based cohort studies","volume":"29","author":"Wiggins","year":"2019","journal-title":"Obes. Surg."},{"key":"10.1016\/j.semcancer.2023.03.002_bib248","first-page":"11","article-title":"The body weight alteration and incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials","author":"Lin","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2023.03.002_bib249","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13668-022-00400-9","article-title":"Nutritional deficiencies before and after bariatric surgery: prevention and treatment","volume":"11","author":"Argyrakopoulou","year":"2022","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13679-022-00470-4","article-title":"The impact of the rate of weight loss on body composition and metabolism","volume":"11","author":"Fogarasi","year":"2022","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib251","first-page":"1029","article-title":"Association between weight cycling and risk of kidney cancer: a prospective cohort study and meta-analysis of observational studies","volume":"32","author":"Lee","year":"2021","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib252","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clgc.2016.06.009","article-title":"Weight loss following radical cystectomy for bladder cancer: characterization and effect on survival","volume":"15","author":"McDonald","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib253","first-page":"259","article-title":"First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH","volume":"30","author":"Griffin","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib254","first-page":"891","article-title":"Patient reported weight loss predicts recurrence rate in renal cell cancer cases after nephrectomy. Asian Pacific","volume":"19","author":"Tiwari","year":"2018","journal-title":"J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2023.03.002_bib255","first-page":"14","article-title":"Gastric carcinoma and renal cell carcinoma as an atypical presentation of multiple primary malignancies: a case report and review of the literature","author":"Mart\u00edn-P\u00e9rez","year":"2020","journal-title":"J. Med Case Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib256","first-page":"36","article-title":"Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer","author":"Okita","year":"2019","journal-title":"Med Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib257","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.suronc.2020.08.006","article-title":"Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer","volume":"35","author":"Wilson","year":"2020","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib258","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Meat, fish and dairy products and the risk of cancer. Available at dietandcancerreport.org."},{"key":"10.1016\/j.semcancer.2023.03.002_bib259","first-page":"12","article-title":"An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites","author":"Papadimitriou","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2023.03.002_bib260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12082188","article-title":"Alcohol consumption and the risk of prostate cancer: a dose-response meta-analysis","volume":"12","author":"Hong","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib261","first-page":"11","article-title":"Association between alcohol consumption and risk of bladder cancer: a dose-response meta-analysis of prospective cohort studies","author":"Lao","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib262","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/bjc.2012.136","article-title":"Alcohol intake and renal cell cancer risk: a meta-analysis","volume":"106","author":"Song","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib263","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2023.03.002_bib264","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mayocpiqo.2019.05.001","article-title":"A clinician\u2019s guide to healthy eating for cardiovascular disease prevention","volume":"3","author":"Pallazola","year":"2019","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"10.1016\/j.semcancer.2023.03.002_bib265","first-page":"22","article-title":"Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis","author":"Dianatinasab","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.semcancer.2023.03.002_bib266","first-page":"98","article-title":"Mediterranean dietary pattern and the risk of prostate cancer a meta-analysis","author":"Cheng","year":"2019","journal-title":"Med (U. S. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib267","first-page":"9","article-title":"Adherence to mediterranean diet and risk of cancer: an updated systematic review and meta-analysis","author":"Schwingshackl","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib268","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3945\/ajcn.2010.29530","article-title":"Fish consumption and prostate cancer risk: a review and meta-analysis","volume":"92","author":"Szymanski","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib269","first-page":"74","article-title":"Consumption of fruits, vegetables and bladder cancer risk: a systematic review and meta-analysis of prospective cohort studies","author":"Xenou","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib270","doi-asserted-by":"crossref","first-page":"27892","DOI":"10.18632\/oncotarget.15841","article-title":"Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib271","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/ajcn\/nqaa215","article-title":"Grain and dietary fiber intake and bladder cancer risk: A pooled analysis of prospective cohort studies","volume":"112","author":"Yu","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcancer.2023.03.002_bib272","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/01635581.2019.1637909","article-title":"Dairy product consumption and bladder cancer risk: a meta-analysis","volume":"72","author":"Wu","year":"2020","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib273","volume":"vol. 32","author":"Alexander","year":"2009"},{"key":"10.1016\/j.semcancer.2023.03.002_bib274","first-page":"14","article-title":"Association between dietary nitrate, nitrite intake, and site-specific cancer risk: a systematic review and meta-analysis","author":"Said Abasse","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib275","first-page":"10","article-title":"Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis","author":"Applegate","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib276","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/ijc.29339","article-title":"Dietary acrylamide and cancer risk: an updated meta-analysis","volume":"136","author":"Pelucchi","year":"2015","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib277","first-page":"13","article-title":"Meta-analysis of the association between the inflammatory potential of diet and urologic cancer risk","author":"Lu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib278","first-page":"11","article-title":"Glycemic index, glycemic load and cancer risk: an updated meta-analysis","author":"Turati","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib279","first-page":"21","article-title":"Consumption of flavonoids and risk of hormone-related cancers: a systematic review and meta-analysis of observational studies","author":"Liu","year":"2022","journal-title":"Nutr. J."},{"key":"10.1016\/j.semcancer.2023.03.002_bib280","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/j.2040-4603.2012.tb00476.x","article-title":"Cancer, physical activity, and exercise","volume":"2","author":"Brown","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib281","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/bjc.2014.77","article-title":"The association between physical activity and bladder cancer: systematic review and meta-analysis","volume":"110","author":"Keimling","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib282","first-page":"10","article-title":"A review on the role of physical activity in cancer prevention: middle east reports","author":"Rayegani","year":"2017","journal-title":"Int J. Cancer Manag"},{"key":"10.1016\/j.semcancer.2023.03.002_bib283","first-page":"427","article-title":"Physical activity and cancer prevention: pathways and targets for intervention","volume":"38","author":"Kast","year":"2008","journal-title":"Sports Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib284","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41416-020-0741-x","article-title":"Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies","volume":"122","author":"Zhang","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib285","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/bjc.2013.37","article-title":"The association between physical activity and renal cancer: systematic review and meta-analysis","volume":"108","author":"Behrens","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib286","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/annonc\/mdy073","article-title":"Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis","volume":"29","author":"Benke","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib287","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.eururo.2011.07.007","article-title":"Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis","volume":"60","author":"Liu","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib288","first-page":"152","article-title":"Leisure time physical activity and risk of prostate cancer: a dose-response meta-analysis","volume":"70","author":"Liu","year":"2018","journal-title":"Minerva Urol. e Nefrol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib289","first-page":"18","article-title":"Physical activity and risk of testicular cancer: a systematic review","author":"Huang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib290","first-page":"187","article-title":"Diabetes mellitus and the risk of cancer","volume":"36","author":"Pandey","year":"2011","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib291","article-title":"Use of antihyperglycemic drugs and risk of cancer in patients with diabetes","author":"S\u00f8ndergaard","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib292","first-page":"98","article-title":"Metformin use and prostate cancer risk","author":"Feng","year":"2019","journal-title":"Med (U. S. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib293","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00125-017-4229-z","article-title":"Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium","volume":"60","author":"Chen","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcancer.2023.03.002_bib294","first-page":"8","article-title":"Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review","author":"Franciosi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib295","article-title":"Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients","volume":"97","author":"Hu","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib296","first-page":"203","article-title":"AMPK and cancer","volume":"107","author":"Wang","year":"2016","journal-title":"EXS"},{"key":"10.1016\/j.semcancer.2023.03.002_bib297","doi-asserted-by":"crossref","first-page":"100449","DOI":"10.18632\/oncotarget.22117","article-title":"The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis","volume":"8","author":"Xiao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.03.002_bib298","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/1381612825666190215123759","article-title":"The relationship between prostate cancer and metformin consumption: a systematic review and meta-analysis study","volume":"25","author":"Ghiasi","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.semcancer.2023.03.002_bib299","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejca.2015.09.027","article-title":"Use of metformin and risk of kidney cancer in patients with type 2 diabetes","volume":"52","author":"Tseng","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/COC.0000000000000512","article-title":"Metformin use and kidney cancer survival outcomes","volume":"42","author":"Nayan","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib301","first-page":"2021","article-title":"The impact of metformin use with survival outcomes in urologic cancers: a systematic review and meta-analysis","author":"Yao","year":"2021","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.semcancer.2023.03.002_bib302","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/annonc\/mdw410","article-title":"Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis","volume":"27","author":"Coyle","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib303","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s13679-020-00378-x","article-title":"The fight against obesity escalates: new drugs on the horizon and metabolic implications","volume":"9","author":"Tsilingiris","year":"2020","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib304","first-page":"42","article-title":"Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis","author":"Vosoughi","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.semcancer.2023.03.002_bib305","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.2337\/db13-1169","article-title":"Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth","volume":"63","author":"Nomiyama","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.semcancer.2023.03.002_bib306","doi-asserted-by":"crossref","unstructured":"Wang J., Kim C.H. Malignancies associated with DPP4 inhibitors and GLP1 receptor agonists: Data from a large real-world database. Https:\/\/DoiOrg\/101200\/JCO20203815_suppl1567 2020;38:1567. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_SUPPL.1567.","DOI":"10.1200\/JCO.2020.38.15_suppl.1567"},{"key":"10.1016\/j.semcancer.2023.03.002_bib307","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/07435800.2021.1955255","article-title":"Differential risk of cancer associated with glucagon-like peptide-1 receptor agonists: analysis of real-world databases","volume":"47","author":"Wang","year":"2022","journal-title":"Endocr. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib308","first-page":"132","article-title":"Sodium\u2011glucose cotransporter\u20112 inhibitors in obesity and associated cardiometabolic disorders: where do we stand? Polish","author":"Vallianou","year":"2022","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib309","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00424-020-02448-4","article-title":"SGLT2 and cancer","volume":"472","author":"Wright","year":"2020","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib310","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2016.67.4044","article-title":"Type 2 diabetes mellitus and cancer: the role of pharmacotherapy","volume":"34","author":"Shlomai","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib311","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/dom.13745","article-title":"Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: a meta-analysis of randomized controlled trials","volume":"21","author":"Dicembrini","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.semcancer.2023.03.002_bib312","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcph.1722","article-title":"SGLT2 inhibitors and bladder cancer: analysis of cases reported in the european pharmacovigilance database","volume":"61","author":"Garc\u00eda","year":"2021","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.semcancer.2023.03.002_bib313","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","article-title":"Peroxisome proliferator-activated receptor \u03b3 in diabetes and metabolism","volume":"25","author":"Rangwala","year":"2004","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib314","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2015.7996","article-title":"Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes","volume":"314","author":"Lewis","year":"2015","journal-title":"JAMA - J. Am. Med Assoc."},{"key":"10.1016\/j.semcancer.2023.03.002_bib315","first-page":"344","article-title":"The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: Nested case-control study","author":"Azoulay","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2023.03.002_bib316","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/aje\/kwn190","article-title":"Antidiabetic medication and prostate cancer risk: a population-based case-control study","volume":"168","author":"Murtola","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib317","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2337\/dc15-1358","article-title":"The use of glyburide compared with other sulfonylureas and the risk of cancer in patients with type 2 diabetes","volume":"38","author":"Tuccori","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semcancer.2023.03.002_bib318","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ucl.2011.04.001","article-title":"The complex interplay between cholesterol and prostate malignancy","volume":"38","author":"Solomon","year":"2011","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.semcancer.2023.03.002_bib319","first-page":"196","article-title":"Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs","author":"Patel","year":"2022","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.semcancer.2023.03.002_bib320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/187152012800228715","article-title":"Statins and protein prenylation in cancer cell biology and therapy","volume":"12","author":"Garcia-Ruiz","year":"2012","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.semcancer.2023.03.002_bib321","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4103\/1008-682X.190327","article-title":"Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review","volume":"19","author":"Tan","year":"2017","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.semcancer.2023.03.002_bib322","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bcp.12210","article-title":"Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials","volume":"77","author":"Zhang","year":"2014","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.semcancer.2023.03.002_bib323","first-page":"769","article-title":"Statin use and risk of bladder cancer: a meta-analysis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib324","first-page":"94","article-title":"The prognostic effect of statin use on urologic cancers: an updated meta-analysis of 35 observational studies","author":"Luo","year":"2015","journal-title":"Med (U. S. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mco.2014.446","article-title":"Potency of non-steroidal anti-inflammatory drugs in chemotherapy","volume":"3","author":"HI\u013dOVSK\u00c1","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib326","first-page":"21","article-title":"Anti-inflammatory drugs as anticancer agents","author":"Zappavigna","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib327","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwq437","article-title":"Nonsteroidal antiinflammatory drugs and bladder cancer: A pooled analysis","volume":"173","author":"Daugherty","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib328","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrurol.2011.219","article-title":"Aspirin and urologic cancer risk: an update","volume":"9","author":"Bosetti","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib329","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4255\/mcpharmacol.09.05","article-title":"Anti-inflammatory agents for cancer therapy","volume":"1","author":"Rayburn","year":"2009","journal-title":"Mol. Cell Pharm."},{"key":"10.1016\/j.semcancer.2023.03.002_bib330","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ijc.28038","article-title":"Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trials","volume":"133","author":"Qin","year":"2013","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib331","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s13668-018-0237-y","article-title":"Folate and Its impact on cancer risk","volume":"7","author":"Pieroth","year":"2018","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib332","doi-asserted-by":"crossref","DOI":"10.1007\/s13679-022-00471-3","article-title":"Obesity, HYPovitaminosis D, and COVID-19: the bermuda triangle in public health","author":"Karampela","year":"2022","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib333","doi-asserted-by":"crossref","unstructured":"Dalamaga M., Muscogiuri G., Paganitsa G., Parvouleskou G., Syriou V., Karagkoynis P., et al. Adherence to the Mediterranean diet is an independent predictor of circulating vitamin D levels in normal weight and non-smoker adults: an observational cross-sectional study 2021;72:848\u2013860. https:\/\/doi.org\/10.1080\/09637486.2021.1878488.","DOI":"10.1080\/09637486.2021.1878488"},{"key":"10.1016\/j.semcancer.2023.03.002_bib334","first-page":"14","article-title":"Obesity and cancer: the role of vitamin D","author":"Shanmugalingam","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib335","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13679-021-00433-1","article-title":"Vitamin D and obesity: current evidence and controversies","volume":"10","author":"Karampela","year":"2021","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib336","first-page":"13","article-title":"Vitamin d intake and the risk of colorectal cancer: an updated meta\u2010analysis and systematic review of case\u2010control and prospective cohort studies","author":"Boughanem","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2023.03.002_bib337","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ijc.25439","article-title":"Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma","volume":"128","author":"Gandini","year":"2011","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib338","first-page":"319","article-title":"Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis","volume":"22","author":"Gilbert","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib339","article-title":"Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis","author":"Robles","year":"2022","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2023.03.002_bib340","first-page":"961","article-title":"Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis","volume":"18","author":"Zhang","year":"2013","journal-title":"J. BUON"},{"key":"10.1016\/j.semcancer.2023.03.002_bib341","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1590\/s1677-5538.ibju.2020.0417","article-title":"Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies","volume":"47","author":"Wu","year":"2021","journal-title":"Int Braz. J. Urol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib342","first-page":"9","article-title":"The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib343","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4103\/0973-1482.231425","article-title":"Relationship between Vitamin D receptor gene polymorphism and renal cell carcinoma susceptibility","volume":"14","author":"Lin","year":"2018","journal-title":"J. Cancer Res Ther."},{"key":"10.1016\/j.semcancer.2023.03.002_bib344","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1007\/s13277-014-1803-6","article-title":"The association between VDR polymorphisms and renal cell carcinoma susceptibility: a meta-analysis","volume":"35","author":"Meng","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib345","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/10799893.2014.919593","article-title":"Association of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: A meta-analysis","volume":"34","author":"Ou","year":"2014","journal-title":"J. Recept Signal Transduct."},{"key":"10.1016\/j.semcancer.2023.03.002_bib346","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s13277-014-2728-9","article-title":"Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis","volume":"36","author":"Liao","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib347","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1159\/000438534","article-title":"Vitamin D deficiency and increased risk of bladder carcinoma: a meta-analysis","volume":"37","author":"Zhang","year":"2015","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.semcancer.2023.03.002_bib348","first-page":"5","article-title":"Association of vitamin C, vitamin D, vitamin e and risk of bladder cancer: a dose-response meta-analysis","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.03.002_bib349","first-page":"13","article-title":"A narrative review of the safety of anti-COVID-19 nutraceuticals for patients with cancer","author":"Bader-Larsen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2023.03.002_bib350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2023.03.002_bib351","first-page":"3","article-title":"Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial","author":"Chandler","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.semcancer.2023.03.002_bib352","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1210\/jc.2012-1451","article-title":"Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance","volume":"97","author":"Marshall","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2023.03.002_bib353","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1024\/0300-9831\/a000494","article-title":"Effect of vitamin D supplementation in prostate cancer: a systematic review of randomized control trials","volume":"88","author":"Petrou","year":"2018","journal-title":"Int J. Vitam. Nutr. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib354","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline","volume":"37","author":"Shapiro","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib355","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1080\/01635581.2020.1819348","article-title":"Effects of High-Dose Vitamin D supplementation on phase angle and physical function in patients with prostate cancer on ADT","volume":"73","author":"Inglis","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib356","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10111536","article-title":"Curcumin against prostate cancer: Current evidence","volume":"10","author":"Termini","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.semcancer.2023.03.002_bib357","first-page":"20","article-title":"Clinical effects of curcumin in enhancing cancer therapy: a systematic review","author":"Mansouri","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib358","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","article-title":"Curcumin downregulates human tumor necrosis factor-\u03b1 levels: a systematic review and meta-analysis ofrandomized controlled trials","volume":"107","author":"Sahebkar","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.semcancer.2023.03.002_bib359","doi-asserted-by":"crossref","unstructured":"Arshiya Ara S., Mudda J.A., Lingappa A., Rao P. Research on curcumin: A meta-analysis of potentially malignant disorders 2016. https:\/\/doi.org\/10.4103\/0973\u20131482.171370.","DOI":"10.4103\/0973-1482.171370"},{"key":"10.1016\/j.semcancer.2023.03.002_bib360","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100066","article-title":"The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19","volume":"8","author":"Kritis","year":"2020","journal-title":"Metab. Open"},{"key":"10.1016\/j.semcancer.2023.03.002_bib361","first-page":"345","article-title":"Curcumin for the treatment of prostate diseases: a systematic review of controlled clinical trials","volume":"vol. 1291","author":"Bagherniya","year":"2021"},{"key":"10.1016\/j.semcancer.2023.03.002_bib362","first-page":"20","article-title":"Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K\/Akt\/mTOR pathway: go four better to treat bladder cancer","author":"Khan","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2023.03.002_bib363","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1871520620666200203143803","article-title":"Therapeutic effects of curcumin against bladder cancer: a review of possible molecular pathways","volume":"20","author":"Ashrafizadeh","year":"2020","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.semcancer.2023.03.002_bib364","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12071801","article-title":"Role of curcumin and (\u2212)-epigallocatechin-3-o-gallate in bladder cancer treatment: a review","volume":"12","author":"Piwowarczyk","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2023.03.002_bib365","first-page":"14","article-title":"Curcumin may prevent basement membrane disassembly by matrix metalloproteinases and progression of the bladder cancer","author":"Wro\u0144ski","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2023.03.002_bib366","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2017.06.002","article-title":"Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review","volume":"74","author":"Rheinheimer","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.semcancer.2023.03.002_bib367","doi-asserted-by":"crossref","unstructured":"Sharma B.R., Kanneganti T.D. NLRP3 inflammasome in cancer and metabolic diseases. vol. 22. 2021.","DOI":"10.1038\/s41590-021-00886-5"},{"key":"10.1016\/j.semcancer.2023.03.002_bib368","first-page":"94","article-title":"Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study","author":"Kuo","year":"2015","journal-title":"Med (U. S. )"},{"key":"10.1016\/j.semcancer.2023.03.002_bib369","first-page":"9","article-title":"Monosodium urate crystals activate the inflammasome in primary progressive multiple sclerosis","author":"Piancone","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib370","first-page":"22","article-title":"Adiporon and other adiponectin receptor agonists as potential candidates in cancer treatments","author":"Nigro","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.03.002_bib371","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0851-z","article-title":"Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1\/ERK-dependent necroptosis","volume":"9","author":"Akimoto","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2023.03.002_bib372","first-page":"9","article-title":"Adiponectin agonist ADP355 attenuates CCL4-induced liver fibrosis in mice","author":"Kumar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2023.03.002_bib373","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-20-0405","article-title":"Leptin antagonism inhibits prostate cancer xenograft growth and progression","volume":"28","author":"Philp","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2023.03.002_bib374","first-page":"17","article-title":"Targeting leptin as a therapeutic strategy against ovarian cancer peritoneal metastasis","author":"Wei","year":"2017","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.semcancer.2023.03.002_bib375","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00432-012-1252-9","article-title":"Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors","volume":"138","author":"Zheng","year":"2012","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib376","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.peptides.2013.03.027","article-title":"Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity","volume":"44","author":"Beccari","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.semcancer.2023.03.002_bib377","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BJ20110438","article-title":"Selection of non-competitive leptin antagonists using a random nanobody-based approach","volume":"441","author":"Zabeau","year":"2012","journal-title":"Biochem J."},{"key":"10.1016\/j.semcancer.2023.03.002_bib378","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajpath.2011.04.026","article-title":"In vivo and in vitro evidence that PPAR\u03b3 Ligands are antagonists of leptin signaling in breast cancer","volume":"179","author":"Catalano","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2023.03.002_bib379","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00280-016-3113-8","article-title":"The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines","volume":"78","author":"Fiedor","year":"2016","journal-title":"Cancer Chemother. Pharm."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X23000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X23000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:05:36Z","timestamp":1760918736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X23000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":376,"alternative-id":["S1044579X23000354"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.002","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}